Model
Edge
Alnylam Pharmaceuticals, Inc.
0001585018
Filing Type
3
Filing Date
10/2/2024
Updated
10/3/24, 2:08 PM
Filing
3
Earnings Release
Exhibits
3
Initial Statement of Beneficial Ownership